Psilera
PrivateLast Round
Seed
May 28, 2026
Total Funding Raised
$13.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Psilera is a biotechnology company that develops groundbreaking first-in-class treatments for neurological disorders by creating a new class of next-generation neuroplastogens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Medical AI
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Psilera Comparables
Compare Psilera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xylo Bio | 79% | |
| Exin Therapeutics | 79% | |
| VCENNA | 79% |
Psilera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 28, 2026 | ||||
| Grant | Oct 2, 2025 | ||||
| Grant | Sep 5, 2024 | ||||
| Seed | Jul 1, 2021 |
Key People
Founding team and executive leadership
Psilera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Baird Inc. | Seed |
| Receptor Partners | Seed |
| NIH RADx | Grant |
| Iter Investments | Seed |
| National Institute on Alcohol Abuse and Alcoholism | Grant |
| University of South Florida Research Foundation | Grant, Seed |
| What If Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 87% MoM.
- May 28, 2026
$9M raised in Seed funding.
Recent news
Latest coverage and updates
- hiresAug 27, 2026
Psilera hired Allyson Gage as Vice President, Clinical Development on Aug 27th '26.
- launchesJun 23, 2026
Psilera Inc. launched novel synthetic platform on Jun 23rd '26.
Psilera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Psilera's valuation, stock price, and market status.
Is Psilera a public or private company?
Psilera is a private company.
What is the current stock price of Psilera?
Psilera is a private company with no public stock price. No recent secondary market data is available.
How much is Psilera worth (valuation)?
Valuation information for Psilera is not publicly available.
Can I buy Psilera stock?
Psilera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Psilera's last funding round?
Psilera's most recent funding round was Seed on May 28, 2026.
Who are the main investors in Psilera?
Key investors in Psilera include Iter Investments.
Will Psilera IPO soon?
No public IPO plans have been announced for Psilera.
How can I track Psilera secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Psilera's secondary market activity and sign up for updates.